Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaina Archer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|June 19, 2018
Maintenance Ketamine Therapy for Treatment-Resistant DepressionShaina Archer, Carson Chrenek, Jennifer Swainson
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 14, 2011
Informatics of newborn screening for congenital hypothyroidism in Alberta 2005-08: flow of information from birth to treatmentJonathan M Dawrant, Daniele Pacaud, Andrew Wade, et al.
Frontiers in Psychiatry|December 5, 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potentialBrittany Chubbs, Jay Wang, Shaina Archer, et al.
Psychiatry Research|May 16, 2026
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesisIsis Lunsky, Gilmar Gutierrez, Xena Wang, et al.
Expert Review of Neurotherapeutics|July 9, 2019
Esketamine for treatment resistant depressionJennifer Swainson, Rejish K Thomas, Shaina Archer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 18, 2011
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative projectDavid M S McHugh, Cynthia A Cameron, Jose E Abdenur, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|June 19, 2018
Maintenance Ketamine Therapy for Treatment-Resistant DepressionShaina Archer, Carson Chrenek, Jennifer Swainson
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 14, 2011
Informatics of newborn screening for congenital hypothyroidism in Alberta 2005-08: flow of information from birth to treatmentJonathan M Dawrant, Daniele Pacaud, Andrew Wade, et al.
Frontiers in Psychiatry|December 5, 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potentialBrittany Chubbs, Jay Wang, Shaina Archer, et al.
Psychiatry Research|May 16, 2026
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesisIsis Lunsky, Gilmar Gutierrez, Xena Wang, et al.
Expert Review of Neurotherapeutics|July 9, 2019
Esketamine for treatment resistant depressionJennifer Swainson, Rejish K Thomas, Shaina Archer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 18, 2011
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative projectDavid M S McHugh, Cynthia A Cameron, Jose E Abdenur, et al.
Pageof 1